CORE-ABR
Sales sheet Request a demo

Pathogen

Ureaplasma parvum / urealyticum

Cell-wall-deficient bacteria frequently present in the lower genitourinary tract, often without disease.

Also: Ureaplasma

Atypical and cell-wall-deficient bacteriaUTI panelSTI panelGraded on the antibiogram

How CORE-ABR grades it

No cell wall, so beta-lactams are inactive. Ureaplasma is intrinsically resistant to clindamycin and does not synthesize folate, so TMP-SMX is inactive.

What the report shows for Ureaplasma parvum / urealyticum

  • Detected or not detected, with Ct, limit of detection and cycles above LOD — see PCR reporting.
  • A short pathogen summary, including colonizer likelihood where it applies.
  • A graded column on the antibiogram, and therapy options by scenario on the P.A.C.T. report.
  • When not detected, it is still listed among targets tested.

Resistance genes CORE-ABR applies

When detected, each of these genes is applied to Ureaplasma parvum / urealyticum only for the agents its mechanism defeats.

tetB / tetMTetracycline resistance9 organisms on panel

Tagged

Decision support only. The treating clinician decides. Molecular genotype does not replace phenotypic susceptibility testing, culture, or public-health reporting. Absence of a detected resistance gene does not establish susceptibility. Organism targets vary by panel; CORE-ABR is configured to the assay each laboratory runs.